P96.2

Clinical Causes: In utero exposure to medications administered to the mother during pregnancy, especially opioids, benzodiazepines, or other central nervous system depressants. Therapeutic use of certain drugs administered directly to the newborn in neonatal intensive care units (NICUs), such as opioids or sedatives, which are discontinued abruptly or tapered. Prolonged or high-dose use of specific medications in neonatal treatments that can lead to dependency. Sudden cessation or reduction of drugs used initially for therapeutic purposes in newborns sensitive to withdrawal effects.

Key Symptoms: Irritability and excessive crying Sleep disturbances or difficulties in sleeping patterns Feeding problems, including poor sucking or vomiting Tremors, hyperreflexia, or increased muscle tone Frequent yawning, sweating, or skin excoriation Diarrhea or increased stool output Respiratory difficulties or nasal congestion Frequent sneezing or nasal rhinorrhea Seizures in severe cases Elevated irritability or inconsolable crying

Diagnosis Path: The diagnosis of withdrawal symptoms in newborns primarily relies on clinical observation of the characteristic symptoms following known or suspected exposure to certain drugs. Healthcare providers may review the newborn’s medical history, including maternal medication use during pregnancy and medications administered post-birth. A detailed physical examination and scoring tools, such as the Finnegan Neonatal Abstinence Scoring System, are often employed to assess the severity of withdrawal. Additional laboratory tests are generally not necessary but may be used to rule out other conditions or complications.

Treatment Protocols: Close monitoring of the infant’s vital signs, feeding, and behavior Providing a calm, quiet environment to reduce overstimulation Gradual tapering or discontinuation of the offending medication if feasible Use of non-pharmacological interventions such as swaddling, skin-to-skin contact, and soothing techniques Administering medications like morphine or methadone in severe cases to mitigate withdrawal symptoms, under strict medical supervision Nutritional support and ensuring adequate caloric intake Addressing complications like dehydration or infections promptly Involving a multidisciplinary team including neonatologists, nurses, and addiction specialists for comprehensive care